179 related articles for article (PubMed ID: 28230864)
21. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
[TBL] [Abstract][Full Text] [Related]
22. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
23. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
[TBL] [Abstract][Full Text] [Related]
24. Novel target genes and a valid biomarker panel identified for cholangiocarcinoma.
Andresen K; Boberg KM; Vedeld HM; Honne H; Hektoen M; Wadsworth CA; Clausen OP; Karlsen TH; Foss A; Mathisen O; Schrumpf E; Lothe RA; Lind GE
Epigenetics; 2012 Nov; 7(11):1249-57. PubMed ID: 22983262
[TBL] [Abstract][Full Text] [Related]
25. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
Fan W; Yang H; Liu T; Wang J; Li TW; Mavila N; Tang Y; Yang J; Peng H; Tu J; Annamalai A; Noureddin M; Krishnan A; Gores GJ; Martínez-Chantar ML; Mato JM; Lu SC
Hepatology; 2017 Apr; 65(4):1249-1266. PubMed ID: 27981602
[TBL] [Abstract][Full Text] [Related]
26. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.
Phoomak C; Park D; Silsirivanit A; Sawanyawisuth K; Vaeteewoottacharn K; Detarya M; Wongkham C; Lebrilla CB; Wongkham S
Mol Oncol; 2019 Feb; 13(2):338-357. PubMed ID: 30444036
[TBL] [Abstract][Full Text] [Related]
27. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
Isomoto H; Mott JL; Kobayashi S; Werneburg NW; Bronk SF; Haan S; Gores GJ
Gastroenterology; 2007 Jan; 132(1):384-96. PubMed ID: 17241887
[TBL] [Abstract][Full Text] [Related]
28. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J
Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676
[TBL] [Abstract][Full Text] [Related]
29. Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma.
Xiong F; Wang D; Xiong W; Wang X; Huang WH; Wu GH; Liu WZ; Wang Q; Chen JS; Kuai YY; Wang B; Chen YJ
J Exp Clin Cancer Res; 2024 May; 43(1):152. PubMed ID: 38812060
[TBL] [Abstract][Full Text] [Related]
30. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
[TBL] [Abstract][Full Text] [Related]
32. Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma.
Yang W; Wang X; Zheng W; Li K; Liu H; Sun Y
Int J Oncol; 2013 Feb; 42(2):690-8. PubMed ID: 23254774
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
[TBL] [Abstract][Full Text] [Related]
34. Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma.
Chen YJ; Luo J; Yang GY; Yang K; Wen SQ; Zou SQ
World J Gastroenterol; 2012 Aug; 18(29):3849-61. PubMed ID: 22876037
[TBL] [Abstract][Full Text] [Related]
35. MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression.
Li J; Tian F; Li D; Chen J; Jiang P; Zheng S; Li X; Wang S
FEBS Lett; 2014 Sep; 588(18):3491-500. PubMed ID: 25131931
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a CpG island methylator phenotype-related prognostic signature for cholangiocarcinoma.
Liang J; Liu T; Liao J; Zhang L; Zhou M; Xu W; He Y; Cai G; Jin G; Song J; Li G; Liang H; Ding Z; Zhang B
J Cell Physiol; 2021 Apr; 236(4):3143-3156. PubMed ID: 32996133
[TBL] [Abstract][Full Text] [Related]
37. Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma.
Wang W; Zhong W; Yuan J; Yan C; Hu S; Tong Y; Mao Y; Hu T; Zhang B; Song G
Oncotarget; 2015 Dec; 6(39):42276-89. PubMed ID: 26474277
[TBL] [Abstract][Full Text] [Related]
38. Rescuing Dicer expression in inflamed colon tissues alleviates colitis and prevents colitis-associated tumorigenesis.
Wu X; Chen X; Liu H; He ZW; Wang Z; Wei LJ; Wang WY; Zhong S; He Q; Zhang Z; Ou R; Gao J; Lei Y; Yang W; Song G; Jin Y; Zhou L; Xu Y; Tang KF
Theranostics; 2020; 10(13):5749-5762. PubMed ID: 32483416
[TBL] [Abstract][Full Text] [Related]
39. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R
Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665
[TBL] [Abstract][Full Text] [Related]
40. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
